Cannabis Suisse Corp NT 10-K, filed Aug 31, 2021
Cannabis Suisse Corp. (CSUI)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
|
|
| |
| SEC FILE NO. 333-213009 |
| CUSIP NUMBER 13767A103 |
| | | | | | | | | | |
|
| |||||||
| |
| | |
|
|
|
|
|
|
|
|
|
|
| ||||
|
| [x] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ]Form 10-D [ ] Form N-SAR [ ] Form N-CSR |
|
| | |
| | |||||||||||
|
|
|
|
| | |
| | |||||||||||
|
| For Period Ended: May 31, 2021 |
|
| | |
| | |||||||||||
|
|
|
|
| | |
| | |||||||||||
|
| [ ] Transition Report on Form 10-K |
|
| | |
| | |||||||||||
|
| [ ] Transition Report on Form 20-F |
|
| | |
| | |||||||||||
|
| [ ] Transition Report on Form 11-K |
|
| | |
| | |||||||||||
|
| [ ] Transition Report on Form 10-Q |
|
| | |
| | |||||||||||
|
| [ ] Transition Report on Form N-SAR |
|
| | |
| | |||||||||||
|
|
|
|
| | |
| | |||||||||||
|
| For the Transition Period Ended: |
|
| | |
| | |||||||||||
| |
| |
| Read Instruction Before Preparing Form. Please Print or Type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
Full Name of Registrant:
Cannabis Suisse Corp.
Former Name if Applicable: Geant Corp.
Address of Principal Executive Office (Street and Number)(Zip Code):
Lerzenstrasse 12, Dietikon, Switzerland, 8953
|
|
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
| | | |
|
| x | (a) | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
|
|
|
|
|
|
| | (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|
|
|
|
|
|
|
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
|
PART III — NARRATIVE
Cannabis Suisse Corp. (the “Company”) is informing the public of its inability to file its Form 10-K for the fiscal year ended May 31, 2021 (the “Form 10-K”) within designated timeframe. The Registrant cannot complete preparation of the Form 10-K without unreasonable effort or expense due to updates in its business operations. The Registrant requires additional time in order to compile and analyze certain information and documentation and complete preparation of its annual financial statements. The Company also needs to enable its independent registered public accounting firm to complete the audit of the financial statements to be included in the Form 10-K.
PART IV — OTHER INFORMATION
| | |
| |
|
|
|
|
| ||||||||
| (1) | Name and telephone number of persons to contact in regard to this notification |
| |
|
|
| ||||||||||
| | | | | |
|
| Suneetha Nandana Silva Sudusinghe |
| (502) |
| 208-2098 |
|
| (Name) |
| (Area Code) |
| (Telephone Number) |
|
| | | | | | | | | | | | |
| |||||
| | | | |
|
|
|
| ||||||||||
| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). [x] Yes [ ] No |
| |
| |||||||||||||
| | | | |
|
| | | | |
| |||||||||||
| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? [ ] Yes [x] No |
| | | | | | ||||||||||||||
|
|
|
| | | | | | ||||||||||||||
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
The statements included in this Form 12b-25 regarding our financial performance and results of operations, in each case as expected to be reported and other statements that are not historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Although we believe the expectations and forecasts reflected in our forward-looking statements are reasonable, we can give no assurance they will prove to have been correct. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. Factors that could cause actual results to differ materially
from expected results include the results and finalization of the Company’s financial statements, audit and reviews and those described under Risk Factors in our most recent Form 10-K and other filings with the U.S. Securities and Exchange Commission.
Cannabis Suisse Corp.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
| |||||
| | |||||||
| Date: August 31, 2021 | By: | /s/ Suneetha Nandana Silva Sudusinghe |
|
| |||
|
|
| Suneetha Nandana Silva Sudusinghe Chief Executive Officer |
|
| |||